Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia

NCT05975996 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Severe Aplastic Anemia

Interventions

DRUG: Cyclophosphamide added to standard immunosuppressive therapy with herombopag

Sponsor

Institute of Hematology & Blood Diseases Hospital, China